• Pemetrexed in Tumor Cell Lines: Optimized Workflows & Insigh

  2026-05-15

  Pemetrexed disodium, a multi-targeted antifolate, is revolutionizing cancer chemotherapy research by enabling precision studies on folate metabolism and synthetic lethality. This guide delivers robust workflow enhancements, troubleshooting strategies, and practical applications in tumor cell models—bridging mechanistic insight with translational impact.

• Syringin Enhances Sunitinib Efficacy in Renal Cell Carcinoma

  2026-05-14

  This study demonstrates that Syringin, a natural compound, inhibits renal cell carcinoma (RCC) cell growth and sensitizes cells to the multi-targeted RTK inhibitor Sunitinib by suppressing the EGFR/PI3K/Akt pathway. The findings highlight a promising strategy for overcoming Sunitinib resistance in RCC, with implications for combination therapy research.

• Radicicol: Hsp90 Inhibitor for Apoptosis and Inflammation As

  2026-05-14

  Radicicol stands out as a benchmark Hsp90 inhibitor—enabling precise modulation of apoptosis, differentiation, and inflammation. This article provides actionable protocols, troubleshooting insights, and advanced use-cases for leveraging Radicicol in translational research, referencing the latest mechanistic and workflow advances.

• ATRX Deficiency Sensitizes High-Grade Glioma to RTK/PDGFR In

  2026-05-13

  Pladevall-Morera et al. (2022) demonstrate that ATRX-deficient high-grade glioma cells are markedly more sensitive to multi-targeted RTK and PDGFR inhibitors. Their combinatorial approach with temozolomide suggests a refined therapeutic window for ATRX-mutant gliomas, underscoring the importance of integrating ATRX status into preclinical and clinical research.

• Artemisinin Counters Diabetic Cognitive Decline via NRF2 Pat

  2026-05-13

  Wang et al. (2024) reveal that artemisinin protects against cognitive dysfunction in type 2 diabetic mice by activating NRF2 and inhibiting neuronal ferroptosis. This mechanistic insight clarifies the interplay between oxidative stress, ferroptosis, and cognitive impairment, with ML385 used to dissect NRF2’s role.

• Paroxetine Does Not Alter Thiothixene Pharmacokinetics in Hu

  2026-05-12

  This study rigorously assessed whether paroxetine, a CYP2D6 inhibitor, affects the pharmacokinetics of thiothixene, a typical antipsychotic agent. Results showed no significant changes in thiothixene clearance following short-term paroxetine pretreatment, clarifying the metabolic independence of thiothixene from CYP2D6 and informing safer co-administration strategies.

• Tigecycline: Glycylcycline Antibiotic for Multidrug Resistan

  2026-05-12

  Tigecycline is a first-in-class glycylcycline antibiotic with proven efficacy against multidrug-resistant bacteria, including carbapenemase gene-harboring Enterobacter cloacae. Its unique mechanism, broad-spectrum activity, and favorable pharmacokinetics make it a valuable tool in tackling complex infections.

• PI3KC2β Suppresses HER2+ Breast Cancer Metastasis via mTORC1

  2026-05-11

  This study identifies PI3KC2β as a novel metastasis suppressor in HER2+ breast cancer, acting through negative regulation of mTORC1 signaling. The findings clarify the mechanistic link between autophagy-related genes and metastatic progression, with implications for targeted therapeutic development.

• Optimizing hiPSC-Derived Platelet Production via Small Molec

  2026-05-11

  This study establishes an optimized protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs), significantly improving efficiency and reducing costs by integrating specific small molecules into the differentiation process. These advances address key challenges in scalable platelet manufacturing and open new directions for cell therapy and disease modeling.

• SUMOylation of Human ANP32A/B Enables Avian Influenza Adapta

  2026-05-10

  This study uncovers how SUMOylation of human ANP32A and ANP32B by PIAS2α facilitates their interaction with the avian influenza virus NS2 protein, overcoming host species restriction. The findings clarify a critical adaptation mechanism for avian influenza polymerase activity in mammalian cells and highlight new avenues for studying host-pathogen interactions.

• Macrophage M1 Polarization via TLR4 Blocks CAC Progression

  2026-05-09

  Liu et al. demonstrate that Jiedu Xiaozheng Yin (JXY) inhibits colitis-associated colorectal cancer (CAC) progression by promoting macrophage polarization toward the M1 phenotype through the TLR4 pathway. Their findings clarify the immunomodulatory mechanisms of JXY and highlight the role of AP-1 pathway modulation in tumor microenvironment control.

• Hexa-Acylated LPS: Gut Microbiota Structure Shapes Cancer Im

  2026-05-09

  This study elucidates how the structural diversity of gut microbiota-derived lipopolysaccharides (LPS), specifically hexa-acylated forms, modulates the host response to immune checkpoint inhibitors in melanoma. Functional metagenomic and translational analyses reveal that enrichment of hexa-acylated LPS-producing bacteria enhances anti-tumor immunity, providing a mechanistic basis for microbiome-informed immunotherapy strategies.

• Capture-and-Release Enables Enhanced Sensitivity in LFAs

  2026-05-08

  A recent study introduces a 'capture-and-release' strategy, termed AmpliFold, to significantly enhance lateral flow assay (LFA) sensitivity. By deploying cleavable linkers and dual-affinity nanoparticles, this method achieves up to 16-fold improvements in detection limits, offering a practical advancement for rapid, point-of-care diagnostics.

• Cy7 NHS Ester (A8109): Practical Guide for NIR Protein Label

  2026-05-07

  Cy7 NHS ester is a sulfonated near-infrared dye designed for robust, water-soluble labeling of proteins and peptides via amino group conjugation. Its hydrophilic profile minimizes quenching and enables sensitive in vivo or in vitro imaging, particularly for biomolecules sensitive to denaturation. It is not suitable for workflows requiring long-term storage of dye solutions or those dependent on organic solvent-based labeling.

• Filipin III: Illuminating Cholesterol Microdomains in Immuno

  2026-05-07

  Discover how Filipin III, a polyene macrolide antibiotic, advances cholesterol detection in biological membranes and supports cutting-edge immunometabolic research. This article uniquely bridges membrane biochemistry with tumor microenvironment insights for next-generation assay design.

450 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page